These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 309555)

  • 1. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Bitran JD
    N Engl J Med; 1978 Dec; 299(23):1317. PubMed ID: 309555
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of immunologic markers in adults with acute lymphoblastic leukemia.
    Baccarani M; Gobbi M; Tura S
    N Engl J Med; 1980 Jan; 302(2):123. PubMed ID: 6965316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-hematologic and prognostic characteristics of immunocytologic subvariants of lymphoblastic leukemia in children].
    Kondratchik KL
    Pediatriia; 1987; (7):87-9. PubMed ID: 3499598
    [No Abstract]   [Full Text] [Related]  

  • 4. Surface markers in human lymphoid leukaemias.
    Nadkarni JJ; Nadkarni JS; Advani SH
    Indian J Cancer; 1978 Dec; 15(4):43-7. PubMed ID: 317270
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia.
    Greaves MF; Lister TA
    N Engl J Med; 1981 Jan; 304(2):119-20. PubMed ID: 6934374
    [No Abstract]   [Full Text] [Related]  

  • 6. Karyotype, immunophenotype, and clinical outcome: correlations in childhood acute lymphoblastic leukemia.
    Gregoire MJ; Peeters MA; Bene MC; Bordigoni P; Faure G; Gilgenkrantz S; Olive D; Streiff F; Duheille J
    Haematol Blood Transfus; 1987; 30():504-8. PubMed ID: 3497848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P; Genter G; Jamra M
    Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lymphoblastic leukemia and immunological markers].
    Ifrah N; Perrot JY; Marie JP; Boasson M; Zittoun R
    Ann Med Interne (Paris); 1987; 138(7):527-32. PubMed ID: 3326452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and immunological characteristics of acute lymphoblastic leukemia.
    Abbadessa V; Citarrella P; Di Marco P; Cajozzo C; Perricone R; Prezioso A; Cajozzo A
    Haematologica; 1982 Oct; 67(5):702-9. PubMed ID: 6816682
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological variants and treatment of lymphoblastic leukemia].
    Shalaev VA
    Gematol Transfuziol; 1986 Jul; 31(7):58-63. PubMed ID: 3527859
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte surface markers in acute lymphoblastic leukemia of adults.
    Garcia JC; Chen YH; Hsu CS
    Am J Clin Pathol; 1977 Nov; 68(5):543-6. PubMed ID: 303458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell markers on lymphoblasts in acute lymphoblastic leukaemia.
    Gajl-Peczalska KJ; Bloomfield CD; Nesbit ME; Kersey JH
    Clin Exp Immunol; 1974 Aug; 17(4):561-9. PubMed ID: 4219600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface markers and prognostic factors in acute lymphoblastic leukemia.
    Tsukimoto I; Wong KY; Lampkin BC
    N Engl J Med; 1976 Jan; 294(5):245-8. PubMed ID: 53789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 16. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
    Brouet JC; Toben HR; Chevalier A; Seligmann M
    Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of B- and T-cell markers on acute lymphoblastic leukaemic cells and persistence of the T-cell marker on mitogen-transformed T-lymphocytes.
    Collins RD; Smith JL; Clein GP; Barker CR
    Br J Haematol; 1974 Apr; 26(4):615-25. PubMed ID: 4136032
    [No Abstract]   [Full Text] [Related]  

  • 18. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers.
    Wolff LJ; Richardson ST; Neiberger JB; Neiburger RG; Irwin DS; Bachner RL
    J Pediatr; 1976 Dec; 89(6):956-8. PubMed ID: 1086896
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunological classification of acute lymphoblastic leukemias.
    Brouet JC; Seligmann M
    Cancer; 1978 Aug; 42(2 Suppl):817-27. PubMed ID: 356954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.